Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LRRC2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NEK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00269 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDELR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MITF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGAPA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THEMIS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NKD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927365 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEUP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPHAR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPH3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AVP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on